Dr Reddy’s reports disappointing Q1FY2017 results
Dr Reddy’s reports disappointing Q1FY2017 result; impacted largely by US business and weak operational performance.
Dr Reddy's Q1: Cons Net Profit -76.3% at Rs153 Cr Vs Rs674.4 Cr (YoY)
Total Income -14.1% at Rs.3, 222.5 Cr Vs Rs.3, 752.2 Cr (YoY)
Cons EBITDA at Rs.400 Cr; EBITDA Margin At 12.3%.
TVS Motor Q1 net profit gains 25% (YoY)
TVS Motor Company Ltd has announced the Q1 Unaudited Standalone results for the quarter ended June 30, 2016 (YoY)
Net Profit rose by 25.15% to Rs121.25 crore Vs Rs100.08 crore (YoY).
Total Income increased by 11.03% to Rs2917.11 crore Vs Rs2595.10 crore (YoY).
EBITDA Margin At 6.9% Vs 6.7% (YoY)
EBITDA +16% at Rs.200 Cr Vs Rs.172.7 Cr (YoY):
Realisations Down 0.5% YoY at Rs.40, 100/unit Vs Rs.40, 300/unit
Maruti Suzuki Q1 net profit up 23% (YoY)
Maruti Suzuki India Ltd has announced the Unaudited Standalone results for the quarter ended June 30, 2016
Net Profit rose by 23.01% to Rs1486.20 crore Vs Rs1208.10 crore (YoY).
Total Income increased by 13.45% to Rs15410.60 crore Vs Rs13583.40 crore (YoY).
EBITDA at Rs2215.7 crore
EBITDA Margin at 14.8%
ACC Q2: Net Profit +81% at Rs237.8 Cr Vs Rs131.4 Cr (YoY)
ACC Q2: Net Profit +81% at Rs237.8 Cr Vs Rs131.4 Cr (YoY)
Total Income -3.3% at Rs.2, 917 Cr Vs Rs.3, 015 Cr (YoY)
EBITDA +36.9% at Rs.456.6 Cr Vs Rs.333.5 Cr (YoY)
EBITDA Margin At 15.7% Vs 11.1% (YoY)
Cement Sales Volume at 6.12 mt Vs 6.20 mt (YoY)
Ajanta Pharma Q1: Cons Net Profit +39% at Rs119.5 Cr
Ajanta Pharma Q1: Cons Net Profit +39% at Rs.119.5 Cr Vs Rs.86 Cr (YoY)
Cons Total Income +20.4% at Rs.471 Cr Vs Rs.391.3 Cr (YoY)
EBITDA At +36% at Rs.166.6 Cr Rs.122.5 Cr (YoY)
Cons EBITDA Margin At 35.4% Vs 31.3% (YoY)
India Branded Biz +19% at Rs.157 Cr YoY.
Read our more services below:
Nifty Options Tips
CapitalStars Giving 2 Days Free Trial Calls..... Hurry Up
CapitalStars Giving 2 Days Free Trial Calls..... Hurry Up
CapitalStars Financial Research Financial Advisory Services
www.capitalstars.com |T:+91-731-6790000,6669900
No comments:
Post a Comment